AN2 Therapeutics, Inc. (ANTX): 10-Q filed Aug 11, 2026

Form type

10-Q

Filing date

Aug 11, 2026

Accession number

0001193125-26-344569

Filer

AN2 Therapeutics, Inc. (CIK 1880438)